Clinical Trials Browser

Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Endometrial Neoplasms

Pancreatic Adenocarcinoma

Neoplasm Metastasis

Colonic Neoplasms

Colorectal Neoplasms

Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Pancreatic Neoplasms

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

Brain Neoplasms, Glioma

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Cancer Metastatic

Squamous Cell Carcinoma of Head and Neck

Colorectal Neoplasms

Colorectal Neoplasms, Dihydropyrimidine Dehydrogenase Deficiency

Advanced Solid Tumors

Colorectal Neoplasms

Breast Neoplasms, Edema, Erythema, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

Colorectal Neoplasms

Neoplasm Metastasis, Neoplasms

Colonic Neoplasms

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Colonic Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Neoplasms, Colorectal Neoplasms

Colonic Neoplasms, Colorectal Neoplasms

Clinical Trials

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial)

EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

CodeBreaK 301

ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

CodeBreak300

Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC

PARERE

Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer

Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver

NIPAVect

HAITI

(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma

VICTORIA

TRIFLUOX-DP

Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)

Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer

AURORAS-1

The Sagittarius Trial

OSCAR

PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC

SAMCO

OPTIPRIME

A Study of Dabrafenib Plus Cetuximab/Panitumumab With FOLFOX in the First Line of Therapy in People With Metastatic Colorectal Cancer

A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment